Jan Marini has spent thirty years building a professional-channel reputation on formulation depth rather than billboard marketing, and NeuroSmooth, launched in 2024, is the brand indulging its experimental streak, pairing the validated peptide standards everyone knows with a couple of genuinely unusual mechanisms you rarely see anywhere in consumer skincare. That experimental character is the most interesting reason to look closely at it, because it's not just another multi-peptide serum hoping the word "peptide" on the box does the selling for it.
The backbone is a six-peptide complex, and the roster is deliberately, almost academically broad. There's acetyl hexapeptide-8 (Argireline) for muscle-relaxing expression-line softening, palmitoyl tetrapeptide-7 as a Matrixyl 3000-class collagen supporter, acetyl tetrapeptide-2 for eye-area anti-aging, and N-prolyl palmitoyl tripeptide-56 acetate delivering Matrixyl Synthe'6-style collagen support, all well-established peptide chemistry with real research behind it. The two that make this formula distinctive are sh-oligopeptide-4, better known as Thymosin Beta-4, a synthetic peptide with emerging research for anti-inflammatory and skin-regenerative function that's genuinely unusual to find in a cosmetic, and dipeptide-2, included for puffiness reduction. Around the peptides sit the brand's more adventurous picks: vitamin K1 oxide (phytonadione epoxide) at the seventh INCI position, a vitamin K derivative with promising evidence for vascular tone evenness and dark-circle support; kangaroo paw flower (Anigozanthos flavidus), an Australian native botanical contributing antioxidant function on an emerging evidence basis; and hesperidin methyl chalcone, a citrus flavonoid that adds further vascular-tone support. Rounding out the supporting cast are arnica for traditional anti-inflammatory action, allantoin for soothing, soybean oil for emollience, and sodium hyaluronate for hydration, the well-established framework that keeps the experimental actives comfortable and stable on the skin. Reading the full INCI, the peptides cluster mid-list while the silicones, emollients, and vitamin K do the early structural work, which is consistent with a serum designed to feel light while still carrying real active payload.
In use it reads as a lightweight cream-serum hybrid that absorbs to a satin finish, leaving skin immediately more cushioned and visibly smoother from the peptide and HA hydration, and it's fragrance-free, which suits the sensitive-leaning, professional-channel positioning. The realistic arc is visible smoothing over four to eight weeks with cumulative pore-appearance and anti-aging benefits accruing toward the twelve-week mark, the patient timeline any peptide serum honestly demands; nobody should expect dramatic shifts in the first week. Because it skips retinoids entirely, it doubles as a pregnancy-safe anti-aging option, which genuinely matters to a meaningful slice of buyers who've had to shelve their vitamin A. The ingredient-quality score of 85 is earned, this is a deep, thoughtfully layered formula, and the broad 80 suitability reflects that it works across normal, combination, and dry skin targeting aging, pore appearance, dullness, and tone unevenness. The vascular-tone angle deserves a second look, too, because the trio of vitamin K1 oxide, hesperidin methyl chalcone, and dipeptide-2 collectively nods toward dark circles and under-eye puffiness, a slightly different ambition than most peptide serums chase; whether that translates into visible under-eye improvement is harder to promise than the smoothing claims, but it's a coherent thread running through the formula rather than a random inclusion, and it explains some of the "glass skin" positioning the brand leans on.
The honest friction starts with price and a few formulation choices that narrow the audience. At $198 for 30ml this is luxury professional-channel pricing, and the value score of 55 reflects the unavoidable truth that the core peptide function can be had for a tiny fraction of the cost elsewhere, so a meaningful part of this premium is buying the emerging mechanisms and the professional-brand polish rather than irreplaceable chemistry. Shea butter and soybean oil rule it out for anyone managing fungal acne, since both can feed Malassezia, so that audience should stop here. Arnica is a recognized sensitizer for arnica-reactive users, and benzyl alcohol sits among the flagged allergens, so the genuinely sensitive should patch test rather than assume the soothing supporting cast renders it universally gentle. Data confidence is medium, a 2024 launch with a few hundred reviews, so the scores lean on formulation analysis as much as on a deep pool of long-term feedback, which is the appropriate, honest posture for something this new and this deliberately experimental.
That experimental quality is also exactly what makes the recommendation easy to frame and easy to be honest about. The right buyer is an existing Jan Marini customer or professional-channel shopper, someone genuinely curious about Thymosin Beta-4, kangaroo paw, and vitamin K1 oxide as emerging mechanisms, and comfortable paying luxury pricing for formulation depth, a pregnancy-safe peptide approach, and the novelty of ingredients that aren't on every other shelf. The wrong buyer is the value-driven shopper who simply wants peptide benefits, because the well-established actives here are available for dramatically less, or anyone with fungal acne, arnica sensitivity, or benzyl-alcohol reactivity. NeuroSmooth isn't pretending to be a bargain or hiding behind hype; it's a sophisticated, slightly adventurous formula that asks you to pay for the breadth of its experiment, and for the audience that finds that experiment genuinely compelling, it delivers precisely that, no more and no less.
